Japan Announces Mixed Drug Price Revisions for FY2026
Japan’s FY2026 drug price revision, which took effect in April 2026, brings another round of pricing cuts under the country’s National Health Insurance (NHI) system. Overall, drug prices were reduced by about 4%, with authorities continuing efforts to control healthcare spending as... Read More